Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 9,960.00
-90.00 (-0.90%)
At close: Aug 3, 2026
Whan In Pharm Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 266,191 | 255,214 | 259,596 | 230,394 | 198,935 | 177,776 |
Revenue Growth | 3.10% | -1.69% | 12.68% | 15.81% | 11.90% | 3.54% |
Gross Profit Gross Profit Growth | 91,759 | 86,404 | 93,665 | 98,943 | 98,658 | 93,359 |
Operating Income Operating Income Growth | 17,120 | 13,019 | 21,495 | 30,170 | 29,810 | 31,276 |
Net Income Net Income Growth | 15,941 | 13,595 | 23,381 | 29,774 | 23,921 | 26,660 |
Earnings Per Share EPS Growth | 956.82 | 857.41 | 1531.45 | 1950.23 | 1566.86 | 1746.00 |
EPS Growth | -24.82% | -44.01% | -21.47% | 24.47% | -10.26% | 13.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 63,617 | 63,720 | 52,581 | 78,457 | 87,292 | 145,962 |
Total Debt Total Debt Growth | 579.15 | 679 | 413.74 | 632.03 | 249.94 | 1,721 |
Net Cash (Debt) Net Cash Growth | 63,038 | 63,041 | 52,167 | 77,825 | 87,042 | 144,241 |
Net Cash Growth | 17.14% | 20.84% | -32.97% | -10.59% | -39.66% | 25.68% |
Net Cash Per Share Net Cash Per Share Growth | 3783.69 | 3975.80 | 3416.99 | 5097.57 | 5701.29 | 9447.84 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 6,078 | 9,044 | 20,693 | 23,197 | 16,851 | 35,318 |
Capital Expenditures CapEx Growth | -2,165 | -2,850 | -27,357 | -30,531 | -33,650 | -4,387 |
Free Cash Flow Free Cash Flow Growth | 3,912 | 6,194 | -6,664 | -7,334 | -16,799 | 30,931 |
Free Cash Flow Growth | 30.57% | - | - | - | - | 109.47% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.47% | 33.86% | 36.08% | 42.95% | 49.59% | 52.52% |
Operating Margin | 6.43% | 5.10% | 8.28% | 13.10% | 14.99% | 17.59% |
Pretax Margin | 7.22% | 5.85% | 10.38% | 14.67% | 14.98% | 19.06% |
Profit Margin | 5.99% | 5.33% | 9.01% | 12.92% | 12.03% | 15.00% |
FCF Margin | 1.47% | 2.43% | -2.57% | -3.18% | -8.44% | 17.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 300.000 | 300.000 | 300.000 | 300.000 | 300.000 | 300.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 2.98% | 2.65% | 2.61% | 2.10% | 1.83% | 1.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.41 | 12.71 | 7.71 | 7.71 | 11.23 | 10.19 |
Forward PE | 8.41 | 12.26 | 8.95 | 10.19 | 11.78 | 10.83 |
P/FCF Ratio | 47.05 | 27.90 | - | - | - | 8.79 |
PS Ratio | 0.69 | 0.68 | 0.70 | 1.00 | 1.35 | 1.53 |